[144] Disc Medicine, Inc. SEC Filing

Rhea-AI Filing Summary

Disc Medicine, Inc. (IRON) filed a Form 144 reporting a proposed sale of 4,080 shares of common stock through Merrill Lynch, with an aggregate market value of $243,780.00. The filing shows the shares were acquired in a private placement from the issuer on 05/01/2020 and paid for in cash. The sale is scheduled to occur on or about 08/22/2025 and the shares are listed as traded on Nasdaq. The filer represents they are not aware of any undisclosed material adverse information about the issuer. No securities were reported sold by the filer in the past three months according to the form.

Insights

Securities Analyst

TL;DR This is a routine Rule 144 notice for a small block of shares from a private placement, suggesting planned insider/affiliate sales rather than major structural change.

The filing documents a proposed sale of 4,080 common shares valued at $243,780 via Merrill Lynch with an approximate sale date of 08/22/2025. The shares were acquired in a private placement on 05/01/2020 and paid in cash, which confirms they are held securities subject to resale conditions under Rule 144. The absence of reported sales in the prior three months implies this transaction is not part of a larger, recent disposal pattern. No earnings, debt, or other financial metrics are provided in the filing, limiting broader financial interpretation.

Corporate Governance Expert

TL;DR The notice appears procedural and compliant, with the signer affirming no undisclosed material information; it does not indicate governance changes.

The filer affirms the Rule 144 representations including lack of material nonpublic information and discloses acquisition details (private placement, 05/01/2020). The use of a broker and explicit aggregate market value provides transparency for market participants. There are no disclosures of related-party transfers, plan adoption dates, or trading plans under Rule 10b5-1 in the form, so governance implications are limited to routine insider selling disclosures.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch One Bryant Park New York NY 10036	4080	243780.00	34765581	08/22/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/01/2020	Private Placement	Issuer			4080	05/01/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Disc Medicine's Form 144 report for ticker IRON?

The Form 144 reports a proposed sale of 4,080 common shares with an aggregate market value of $243,780.00 through Merrill Lynch, scheduled around 08/22/2025.

When and how were the shares being sold acquired according to the filing?

The filing states the shares were acquired in a private placement from the issuer on 05/01/2020 and paid for in cash.

Does the filer report any other share sales in the past three months?

No. The filing indicates Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker and exchange are listed in the Form 144?

The broker is listed as Merrill Lynch One Bryant Park New York NY 10036 and the exchange is Nasdaq.

Does the Form 144 indicate the filer knows of any undisclosed material information?

By signing the notice, the filer represents they do not know any material adverse information